Natixis Maravai Lifesciences Holdings, Inc. Transaction History

Natixis

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$4.7 - $9.87 $1.79 Million - $3.76 Million	-380,685 Reduced 93.28%	27,423 $179,000
Q3 2023 Nov 14, 2023	SELL	$9.14 - $12.85 $12.7 Million - $17.9 Million	-1,394,035 Reduced 77.35%	408,108 $4.08 Million
Q2 2023 Aug 11, 2023	BUY	$12.09 - $15.0 $18 Million - $22.3 Million	1,489,716 Added 476.82%	1,802,143 $22.4 Million
Q1 2023 May 12, 2023	BUY	$12.99 - $16.48 $4.06 Million - $5.15 Million	312,427 New	312,427 $4.38 Million
Q2 2022 Aug 12, 2022	SELL	$26.05 - $37.48 $26.1 Million - $37.5 Million	-1,000,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$24.46 - $40.92 $24.5 Million - $40.9 Million	1,000,000 New	1,000,000 $35.3 Million

234

140M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $738M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.